Public Company News
TGE's Global Hospitality Portfolio exceeds US$860 million
PARIS and NEW YORK and LONDON, June 12, 2026 /PRNewswire/ -- AMTD Group Inc. ("AMTD Group"), AMTD IDEA Group ("AMTD IDEA")(NYSE: AMTD; SGX: HKB), AMTD Digital Inc. (NYSE: HKD) and The Generation Essentials Group ("TGE") (NYSE: TGE; LSE: TGE), a subsidiary of AMTD Digital Inc., (altogether, the "G...
2026-06-12 21:20
5093
Wondershare Filmora Launches New Football-Themed Creative Assets and Global Creator Challenge to Celebrate the Season's Biggest Football Moments
VANCOUVER, BC, June 12, 2026 /PRNewswire/ -- Wondershare, a global leader in digital productivity and creativity software, today announced that its flagship video editing software, Wondershare Filmora, has rolled out a new suite of football-themed creative resources and launched the "My Football ...
2026-06-12 20:44
7803
Cheche Group Announces Results of Extraordinary General Meeting
BEIJING, June 12, 2026 /PRNewswire/ -- Cheche Group Inc.
2026-06-12 20:30
9297
Baidu's Apollo Go Expands European Footprint as AmiGo, in Partnership with PostBus, Receives Level 4 Regulatory Approval in Switzerland
* AmiGo, an on-demand autonomous mobility service between Baidu's Apollo Go and Swiss Post's PostBus, has received a special permit from Switzerland's Federal Roads Office (FEDRO) for Level 4 autonomous operations in Eastern Switzerland, confirming the service meets Switzerland's rigorous safet...
2026-06-12 19:47
6347
51Talk Online Education Group Announces First Quarter 2026 Results
SINGAPORE, June 12, 2026 /PRNewswire/ -- 51Talk Online Education Group ("51Talk" or the "Company") (NYSE American: COE), a global online education platform with core expertise in English education, announced its unaudited results for the first quarter ended March 31, 2026. First Quarter 2026 Fin...
2026-06-12 19:00
13880
JinkoSolar Announces Cash Dividend
SHANGRAO, China, June 12, 2026 /PRNewswire/ -- JinkoSolar Holding Co., Ltd. ("JinkoSolar" or the "Company") (NYSE: JKS), a global leader in clean energy technology, today announced that its board of directors has declared a cash dividend of US$0.375 per ordinary share of US$0.00002 each of the Co...
2026-06-12 18:00
8698
Tuya Smart Partners with Zeroth to Develop Robot-Driven Smart Living Experiences, Bringing Physical AI into the Home
The collaboration integrates Tuya's AI+IoT capabilities with Zeroth's embodied intelligence expertise, transforming home robots from standalone task executors into intelligent, context-aware household companions. GUANGZHOU, China, June 12, 2026 /PRNewswire/ -- Tuya Smart (NYSE: TUYA; HKEX: 2391)...
2026-06-12 17:05
5869
XPENG X9 Tops Range and Charging Performance in World's Largest EV Test
—— 11% above WLTP to 646 km and 12m55s charge secure double victory at NAF El Prix Summer 2026 AMSTERDAM, June 12, 2026 /PRNewswire/ -- The XPENG X9 recorded the largest positive deviation from WLTP range and the fastest charging time among all vehicles tested in the summer edition of El Prix 2...
2026-06-12 17:00
4426
Simcere Pharmaceutical Enters into a Research Collaboration Agreement with Stanford Medicine to Develop Innovative Therapies for Patients with Idiopathic Pulmonary Fibrosis
SHANGHAI, June 12, 2026 /PRNewswire/ -- On May 29, 2026, Pacific Time, Simcere Pharmaceutical Group Limited (2096.HK) entered into a research collaboration agreement with Stanford Medicine to jointly advance an exploratory study in the respiratory field, with the aim of developing innovative ther...
2026-06-12 14:59
5784
Akeso's Gumokimab (AK111, Anti-IL-17) Approved by NMPA for Moderate-to-Severe Plaque Psoriasis, Bolstering Its Autoimmune Disease Portfolio
HONG KONG, June 11, 2026 /PRNewswire/ -- Akeso, Inc. (9926.HK) today announced that the National Medical Products Administration (NMPA) of China has approved gumokimab(AK111), the company's internally-developed anti-IL-17 monoclonal antibody, for the treatment of adult patients with moderate-to-s...
2026-06-12 09:57
5408
Harbour BioMed Appoints Dr. Dhavalkumar Patel as Scientific Advisor
CAMBRIDGE, Mass., ROTTERDAM, Netherlands and SHANGHAI, June 11, 2026 /PRNewswire/ -- Harbour BioMed (the "Company"; HKEX: 02142), a global biopharmaceutical company committed to the discovery and development of novel antibody therapeutics in immunology, oncology and other disease areas, today an...
2026-06-12 09:19
6371
Noah Holdings Limited Announces Results of Annual General Meeting and Payment of Final Dividend and Special Dividend
SINGAPORE, June 11, 2026 /PRNewswire/ -- Noah Holdings Limited ("Noah" or the "Company") (NYSE: NOAH and HKEX: 6686), a leading and pioneer wealth management service provider offering comprehensive one-stop advisory services on global investment and asset allocation primarily for global Chinese h...
2026-06-11 21:27
10141
SAIHEAT Expands Business into AI Inference Services, Delivering Tokens of Open Models to Enterprises
SINGAPORE, June 11, 2026 /PRNewswire/ -- SAIHEAT Limited (NASDAQ: SAIH) today announced its strategic expansion into the AI inference services business. It delivers enterprise-level authorizedtoken access to mainstream open-source AI models, with our existing and prospective partners covering Kim...
2026-06-11 20:30
10217
LEIFRAS Co., Ltd. Achieves Multi-Sport School Presence Across All 47 Prefectures in Japan on Its 25th Anniversary
4,500-School Nationwide Network Sets the Stage for Accelerated Expansion in School Club Support, Child Welfare, and Strategic M&A TOKYO, June 11, 2026 /PRNewswire/ -- LEIFRAS Co., Ltd. (Nasdaq: LFS) (the "Company" or "Leifras"), a sports and social business company dedicated to youth sports and ...
2026-06-11 20:30
8364
Nota AI Has Two MoE Quantization Papers Accepted at ICML 2026 Workshop, Demonstrating Global Competitiveness in Large-Scale AI Optimization
* Two papers on MoE-specific quantization algorithms accepted at a workshop held in conjunction with ICML 2026 * Recognition follows Nota AI's overall win at the NVIDIA Nemotron Hackathon * Strengthening core optimization technologies to make large-scale AI models smaller and more efficient ...
2026-06-11 20:00
4977
As AI Infrastructure Takes Center Stage, Neurovia AI Highlights NeuroStream™ and New Leadership at UAE Industry Summit
ABU DHABI, UAE, June 11, 2026 /PRNewswire/ -- Robo.ai Inc. (NASDAQ: AIIO) announced that its wholly-owned subsidiary, Neurovia AI, officially participated in the 2026 UAE Data Center Infrastructure & Cloud Summit as an OFFICIAL AI INFRASTRUCTURE PARTNER. The event, held today in Abu Dhabi, marked...
2026-06-11 18:33
5974
Trip.com Group Limited to Report First Quarter of 2026 Financial Results on June 24, 2026 U.S. Time
SINGAPORE, June 11, 2026 /PRNewswire/ -- Trip.com Group Limited (Nasdaq: TCOM; HKEX: 9961), a leading one-stop travel service provider of accommodation reservation, transportation ticketing, packaged tours and corporate travel management, will announce its financial results for the three months e...
2026-06-11 18:00
6870
CS2009 (PD-1/VEGF/CTLA-4 Trispecific Antibody) ASCO 2026 Key Highlights
SUZHOU, China, June 11, 2026 /PRNewswire/ -- The clinical datasets presented at ASCO 2026by CStone further validate the trispecific synergistic mechanism of CS2009 and support its potential to become a next-generation immuno-oncology (I/O) backbone therapy. I. Trispecific Design Rationale and Di...
2026-06-11 14:20
5390
Caliway Unveils Latest OI25 Animal Study Data for CBL-514 in Combination with GLP-1R-Based Weight-Loss Therapies at ADA 2026, Demonstrating Dual Potential to Attenuate Post-Discontinuation Weight Regain and Improve Metabolic Health
Backed by International Authority — Caliway's latest preclinical data on its proprietary localized fat reduction candidate, CBL-514, in combination with GLP–1R–based weight–loss therapies, were presented at the American Diabetes Association 2026 Scientific Sessions (ADA 2026). The findings were d...
2026-06-11 12:54
4481
Elixiron Immunotherapeutics Reports Positive Phase 2 Interim Results for Enrupatinib: Evidence of Neuroinflammation Reduction and Early Cognitive Benefit in Alzheimer's Disease
CAMBRIDGE, Mass. and TAIPEI, June 10, 2026 /PRNewswire/ -- Elixiron Immunotherapeutics (TPEx: 7871), a clinical-stage biopharmaceutical company pioneering precision immunotherapy for neurodegenerative and autoimmune diseases, today announced positive interim results from its ongoing Phase 2 proo...
2026-06-11 10:56
5545
Week's Top Stories
Most Reposted
DBS crowned Southeast Asia's most valuable brand in Kantar BrandZ 2026 ranking
[Picked up by 305 media titles]
2026-07-15 12:00
Visa Reimagines Visa Infinite for Asia Pacific's Modern Affluent
[Picked up by 300 media titles]
2026-07-16 10:00
A New Chapter Beckons: Four Seasons Resorts of Asia Celebrates Parenthood with Babymoon Offerings
[Picked up by 295 media titles]
2026-07-10 13:30
Gnomey Hollows Opens at PARKROYAL COLLECTION Marina Bay, Singapore, Extending the Hotel's Gnome-Themed Family Experience
[Picked up by 289 media titles]
2026-07-13 11:42
Tetra Pak Introduces Industry-first Carton Packaging for Shelf-stable Tuna to Support Southeast Asia's Growing Tuna Industry
[Picked up by 287 media titles]
2026-07-13 10:00
Most Read
NYSE Content Update: Samos Energy Acquisition to Make NYSE Debut
2026-07-10 21:04
10018
Elong Power Holding Limited Announces Pricing of US$6.6 Million Public Offering
2026-07-10 20:30
9583
Waton Financial Launches MoTA Alpha, Marking Full Strategic Pivot to AI-Native Finance
2026-07-10 10:32
7910